Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer

Published:2014-06 Issue:9 Volume:50 Page:1602-1609
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Angelergues Antoine,Maillet Denis,Fléchon Aude,Ozgüroglu Mustafa,Mercier Florence,Guillot Aline,Le Moulec Sylvestre,Gravis Gwenaelle,Beuzeboc Philippe,Massard Christophe,Fizazi Karim,de La Motte Rouge Thibault,Delanoy Nicolas,Elaidi Reza-Thierry,Oudard Stéphane

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Current and emerging treatment modalities for metastatic castration-resistant prostate cancer;Bracarda;BJU Int,2011

2. Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors;Mita;Clin Cancer Res Off J Am Assoc Cancer Res,2009

3. Preclinical antitumor activity of cabazitaxel, a semi-synthetic taxane active in taxane-resistant tumors;Vrignaud;Clin Cancer Res,2013

4. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;De Bono;Lancet,2010

5. Cabazitaxel in metastatic castration-resistant prostate cancer;Yap;Expert Rev Anticancer Ther,2012

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flare phenomenon visualized by 99mTc-bone scintigraphy has prognostic value for patients with metastatic castration-resistant prostate cancer;Annals of Nuclear Medicine;2024-03-13

2. Prevalence and Prognostic Implications of PSA Flares during Radium-223 Treatment among Men with Metastatic Castration Resistant Prostate Cancer;Journal of Clinical Medicine;2023-08-28

3. Left testicular and pulmonary metastases of mucinous adenocarcinoma of the prostate after robot‐assisted radical prostatectomy;IJU Case Reports;2023-04-13

4. Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis;Urologic Oncology: Seminars and Original Investigations;2023-04

5. Second generation androgen receptor antagonist, TQB3720 abrogates prostate cancer growth via AR/GPX4 axis activated ferroptosis;Frontiers in Pharmacology;2023-01-20